Helix Acquisition and BridgeBio Oncology receive SEC approval for merger
Go back to Helix Acquisition and BridgeBio Oncology receive SEC approval for merger| (NASDAQ: BBIO) | Delayed: 77.19 +2.67 (3.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.52 | 52 Week High | $ | |||
| Open | $75.03 | 52 Week Low | $ | |||
| Day High | $77.26 | P/E | N/A | |||
| Day Low | $74.49 | EPS | $ | |||
| Volume | 3,179,471 | |||||
| (NASDAQ: HLXB) | Delayed: 9.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.90 | 52 Week High | $ | |||
| Open | $9.90 | 52 Week Low | $ | |||
| Day High | $9.90 | P/E | N/A | |||
| Day Low | $9.90 | EPS | $ | |||
| Volume | 355,929 | |||||

